Stay updated on Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Sign up to get notified when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.

Latest updates to the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page
- Check7 days agoChange DetectedA new revision (v3.5.3) was added to the record history, replacing the previous revision (v3.5.2), signaling an updated version of the study record.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe record history now shows Revision: v3.5.2 added and Revision: v3.5.0 removed.SummaryDifference0.1%

- Check28 days agoChange DetectedThe new screenshot shows updated version entries in the record history, reflecting changes to study status, design, and related fields over time.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.5.0 was added to the history, and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded Revision: v3.4.3 to the history. Removed Revision: v3.4.2 from the history.SummaryDifference0.1%

- Check64 days agoChange DetectedThe history shows updates to the study record across versions, including changes to Study Status, Recruitment Status, and sections such as Outcome Measures and Eligibility. It also highlights QC/Quality Control Review status across versions.SummaryDifference0.1%

Stay in the know with updates to Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.